Trademark: 79251923
Status Date
Tuesday, January 7, 2020
Registration Number
5952326
Registration Date
Tuesday, January 7, 2020
Filing Date
Friday, November 2, 2018
Published for Opposition
Tuesday, October 22, 2019
5 Nucleic acid medicines for use in the treatment and prevention of genetic disorders; synthetic biomolecules, namely, synthetic nucleoside, synthetic nucleotide and synthetic nucleic acid for clinical or medical use in the treatment and prevention of genetic disorders
Jul 3, 2022
New Representative At Ib Received
May 8, 2020
Final Decision Transaction Processed By Ib
Apr 18, 2020
Final Disposition Notice Sent To Ib
Apr 18, 2020
Final Disposition Processed
Apr 7, 2020
Final Disposition Notice Created, To Be Sent To Ib
Jan 7, 2020
Registered-Principal Register
Oct 22, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 22, 2019
Published For Opposition
Oct 19, 2019
Notification Processed By Ib
Oct 2, 2019
Notification Of Possible Opposition Sent To Ib
Oct 2, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 2, 2019
Notification Of Notice Of Publication E-Mailed
Sep 18, 2019
Approved For Pub - Principal Register
Sep 17, 2019
Teas/Email Correspondence Entered
Sep 17, 2019
Correspondence Received In Law Office
Sep 17, 2019
Teas Response To Office Action Received
Apr 5, 2019
Refusal Processed By Ib
Mar 18, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Mar 18, 2019
Refusal Processed By Mpu
Mar 8, 2019
Application Filing Receipt Mailed
Mar 7, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Mar 6, 2019
Non-Final Action Written
Mar 4, 2019
Assigned To Examiner
Mar 4, 2019
New Application Office Supplied Data Entered In Tram
Feb 15, 2019
Limitation From Original Application Entered
Feb 14, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
